- Home
- COCH
COCH
Envoy Medical Inc.
as 03-31-2025 12:34pm EST
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | WHITE BEAR LAKE |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $8.00 | AVG Volume (30 days): | 18.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.28 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.21 - $7.20 | Next Earning Date: | 05-14-2025 |
| Revenue: | $278,000 | Revenue Growth: | 15.35% |
| Revenue Growth (this year): | -10.16% | Revenue Growth (next year): | 19.76% |
Latest Envoy Medical Inc. News
COCH Breaking Stock News: Dive into COCH Ticker-Specific Updates for Smart Investing
Newsfile
4 hours ago
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Newsfile
14 days ago
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
Newsfile
19 days ago
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
Newsfile
21 days ago
Envoy Medical to Participate in the 37th Annual ROTH Conference
Newsfile
a month ago
First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant
Newsfile
a month ago
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio
Newsfile
3 months ago
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
GlobeNewswire
3 months ago
Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss
Compare COCH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COCH Envoy Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.